T1	Participants 86 195	intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients
T2	Participants 391 424	aggressive non-Hodgkin's lymphoma
T3	Participants 718 812	patients in first complete remission with intermediate- and high-grade non-Hodgkin's lymphoma.
T4	Participants 834 916	Patients were younger than 55 years and had at least one adverse prognostic factor
T5	Participants 1018 1048	Patients in complete remission
